How Mycotoxin Binders Work: Clays, Enzymes, and Risks

Mycotoxin binders are feed additives designed to grab toxic fungal metabolites in the gut of livestock and carry them out before they can be absorbed into the bloodstream. The concept is straightforward: mix a substance into animal feed that has a stronger chemical attraction to the toxin than the intestinal wall does. In practice, the science is far messier than that pitch suggests. Some binders work brilliantly against one class of mycotoxin and fail completely against another, and certain products carry the risk of also trapping nutrients the animal needs.

How the Binding Actually Works

The most studied mycotoxin binders are clay minerals, and the best-understood interaction is between smectite clays and aflatoxin B1. The toxin slips into the spaces between clay layers, a region chemists call the interlayer gallery. Research on the aflatoxin–smectite complex shows that under dry conditions, the main forces holding the toxin to the clay are interactions between the clay’s exchangeable metal ions and the carbonyl groups on the aflatoxin molecule. Under humid conditions closer to what exists inside a gut, hydrogen bonding through the water molecules surrounding those metal ions takes over as the dominant force.¹ The dicarbonyl system on the aflatoxin molecule is essential for tight binding, and adsorption occurs at multiple sites on clay particles, including edges and basal surfaces as well as the interlayer.²

This chemistry matters because it explains why clays are so effective against aflatoxins specifically. The aflatoxin molecule is small, flat, and polar enough to fit neatly between clay layers and form stable electrostatic bonds. Other mycotoxins have different shapes and charge distributions, and they simply do not dock onto the same binding sites with the same enthusiasm.

Clay Minerals and the Aflatoxin Sweet Spot

Hydrated sodium calcium aluminosilicate, usually abbreviated HSCAS, was one of the first clay products studied for mycotoxin binding and remains a common commercial ingredient. Bentonite and montmorillonite are related smectite clays that show up in many products. In lab and animal studies, these materials reliably bind aflatoxin B1 at rates above 90%. A comparative review found average adsorption capacities of about 76% for montmorillonite, 62% for bentonite, and 55% for HSCAS across multiple mycotoxins tested together, though aflatoxin-specific rates tend to run higher than those averages.³ One in vitro study testing multiple commercial products found that all sequestering agents bound aflatoxin B1 at rates above 92%.⁴

Zeolites, particularly clinoptilolite, are another class of mineral binder. They work through a different mechanism involving their cage-like crystal structure rather than flexible interlayers, and their overall mycotoxin-binding capacity tends to sit somewhat lower, around 52% in the same comparative review.⁵ Still, they remain popular in commercial blends and have the advantage of being widely available and inexpensive.

The Deoxynivalenol Problem

If aflatoxin binding is the success story of this field, deoxynivalenol is its biggest frustration. DON, also called vomitoxin, is one of the most common mycotoxins in grain-based animal feed worldwide. It is produced by Fusarium molds and causes feed refusal, poor growth, and immune suppression in livestock. And almost no binder can grab it.

The chemistry explains why. DON is a small, highly water-soluble molecule that lacks the flat aromatic structure and strong polar groups that make aflatoxins stick to clay surfaces. In one study, the average adsorption rate for DON across all tested binding agents was only about 0.5% under acidic conditions and around 6% under basic conditions.⁶ Research testing a battery of substances found that none of the tested clays, yeast products, or other binders could bind DON in any meaningful percentage.⁷

Activated charcoal is the notable exception. Its massive surface area and porous structure give it a less selective but broader grip on organic molecules. In one comparison, activated charcoal sequestered DON at over 99%, vastly outperforming every other product tested.⁸ That same broad affinity, however, is a double-edged sword, as activated charcoal also binds vitamins, amino acids, and other nutrients the animal needs.

Yeast Cell Wall Products

The organic alternative to mineral clays is products derived from yeast cell walls, usually from Saccharomyces cerevisiae. The active component is beta-D-glucan, a polysaccharide that forms a helical structure capable of trapping certain mycotoxins inside it. Research has shown that the amount of beta-D-glucan in the cell wall correlates directly with how much zearalenone the product can bind.⁹

The mechanism is more complex than simple surface adsorption. Structural studies using X-ray diffraction and molecular modeling have found that the beta-glucan chain forms a single helix with six sugar units per turn, and zearalenone fits inside this helix. The complex is stabilized by both hydrogen bonds and van der Waals forces, with branching side chains helping to lock the toxin in place.¹⁰ This makes yeast-wall products particularly good at capturing zearalenone, and some studies have confirmed that selected smectite clays and yeast-wall-derived products bound zearalenone at rates above 70% even when other binders failed.¹¹

One important wrinkle: yeast-wall binding is pH-sensitive. Zearalenone adsorption by yeast products peaked at about 75% at pH 5 but dropped to around 60% at pH 3 and pH 7. Ochratoxin A was only meaningfully adsorbed at pH 3, reaching about 50%.¹² Since pH varies dramatically between the stomach and the intestine, a product performing well in one in vitro test at a fixed pH may not deliver the same results in a live animal.

For aflatoxin reduction in dairy cow milk, yeast cell wall products consistently rank below clay-based binders. A network meta-analysis found that while all tested binder types reduced aflatoxin M1 transfer into milk compared to control diets, bentonite achieved the highest reduction (about 40%) while yeast cell wall products achieved the lowest (about 25%).¹³

Synthetic Polymers and Cholestyramine

Beyond natural clays and yeast, a handful of synthetic materials have shown promise. Cholestyramine, a resin originally developed to lower cholesterol in humans, has proven to be one of the strongest binders for zearalenone and fumonisins in laboratory tests.¹⁴ In one comparison, cholestyramine outperformed montmorillonite, bentonite, and sepiolite for zearalenone binding, and crospovidone (another synthetic polymer) placed second, binding roughly 314 micrograms of zearalenone per gram of adsorbent compared to around 192 for montmorillonite.¹⁵

These synthetic options have mostly stayed in the research world rather than becoming mainstream feed additives. Cost is one reason. Cholestyramine is a pharmaceutical-grade product, and using it at scale in animal feed is not economically practical for most operations. There are also regulatory hurdles, since feed additive approval frameworks in the EU and elsewhere require specific efficacy and safety data before a substance can be marketed for mycotoxin reduction.

Organically Modified Clays

One of the more interesting research directions involves taking a standard clay mineral and chemically tweaking it to expand its binding range. Natural montmorillonite, for instance, has essentially zero capacity for zearalenone because the mineral surface is too hydrophilic to attract the relatively nonpolar zearalenone molecule. But when researchers exchange the clay’s natural metal ions for large organic cations with long carbon chains, the interlayer space becomes hydrophobic and starts to grab nonpolar toxins. Clays modified with 16-carbon alkyl chains showed the strongest zearalenone binding.¹⁶

A related approach uses nonionic surfactants to modify montmorillonite. This boosted aflatoxin B1 capacity from about 0.5 mg/g in raw clay to nearly 2.8 mg/g, and created zearalenone capacity where there had been none, reaching about 8.5 mg/g.¹⁷ These modified clays are promising because they could handle multiple mycotoxins simultaneously, something unmodified clays struggle to do. They remain largely at the research stage, but the idea of a single binder effective against both polar aflatoxins and less polar Fusarium toxins is a major goal for the industry.

When Binding Is Not Enough, Enzymes Step In

For mycotoxins like DON that resist adsorption by nearly every binder on the market, an entirely different strategy exists: enzymatic degradation. Rather than trapping the toxin and dragging it through the gut intact, specific enzymes break the toxin molecule apart into something harmless. DON’s toxicity depends on its epoxide ring, a small, strained chemical structure. Enzymes that open this ring convert DON into a metabolite called DOM-1, which is generally considered nontoxic.¹⁸

One recently characterized enzyme comes from the wheat resistance gene Fhb7, which codes for a glutathione-S transferase that opens DON’s epoxide ring using the cell’s own glutathione supply.¹⁹ This enzyme was originally identified in a wild grass relative of wheat and has attracted interest both for breeding DON-resistant crops and as a potential feed additive. Other microbial enzymes capable of de-epoxidation have been found in rumen bacteria and soil microbes, though scaling these up for commercial feed use remains a challenge.

Many modern commercial mycotoxin management products now combine a clay-based binder for aflatoxins with an enzymatic or microbial component targeting Fusarium toxins. This blended approach implicitly acknowledges that no single mechanism works across all the toxins that commonly contaminate grain.

The Risk of Binding Nutrients Along With Toxins

A binder that cannot distinguish between a mycotoxin and a vitamin is a problem. The same chemical properties that make clays and activated charcoal effective at grabbing toxins also make them capable of grabbing amino acids and water-soluble vitamins. In vitro testing has confirmed that mycotoxin binders show a high degree of adsorption for amino acids and water-soluble vitamins, which could reduce their bioavailability to the animal.²⁰

Activated charcoal, despite its impressive broad-spectrum toxin binding, is the worst offender here. Its enormous surface area binds almost anything organic, including nutrients the animal cannot afford to lose. This is why nutritionists often recommend using the most selective binder possible rather than the most powerful one. If your main contamination risk is aflatoxin, a well-characterized smectite clay will bind the target toxin efficiently while leaving most nutrients alone. Reaching for activated charcoal as a catch-all solution may reduce mycotoxin exposure at the cost of subclinical nutrient deficiency, especially for vitamins like thiamine and folic acid that are already borderline in some diets.

What Happens in the Animal

Lab tests are one thing, but performance in a live animal is what matters to a farmer. In broiler chickens fed diets contaminated with ochratoxin A and T-2 toxin, adding a mycotoxin binder significantly improved weight gain (from about 76.6 to 82.3 grams per day) and feed conversion during the finisher period.²¹ Similarly, broilers given aflatoxin-contaminated feed showed improved body weight gain when a compound toxin binder was included, along with recovery in blood biochemistry and antioxidant markers.²²

Beyond simple growth metrics, there is evidence that binders affect gut health at the molecular level. In piglets fed DON-contaminated diets, adding a mycotoxin binder reduced expression of toll-like receptor 4, a protein involved in inflammatory signaling in the gut lining, and increased expression of zona occludens 1, a tight junction protein that helps maintain the intestinal barrier.²³ Loosely translated, the binder helped keep the gut wall sealed and less inflamed, which is exactly what you want when an animal is under mycotoxin stress.

Protecting Milk From Aflatoxin Carry-Over

When a dairy cow eats aflatoxin B1, her liver converts a fraction of it into aflatoxin M1, which ends up in the milk. This is a direct food safety issue for humans, and many countries regulate maximum M1 levels in milk. Binders fed to the cow can reduce the amount of B1 that reaches her bloodstream, which in turn reduces M1 in milk.

A network meta-analysis pooling data from multiple dairy cow trials found that bentonite reduced milk aflatoxin M1 by about 40%, HSCAS by a comparable margin, and yeast cell wall products by roughly 25%.²⁴ A systematic review noted that sodium bentonite at about 1.2% of the diet has been reported to achieve reductions of around 65% in some individual studies.²⁵ A field study in Pakistan using clay-based binders documented a progressive decrease in milk M1 levels, dropping about 20% by day four and over 50% by day seven, along with improvements in milk fat, protein, and solids.²⁶

These reductions are meaningful but not complete. No binder tested to date eliminates M1 from milk entirely, which is why contaminated feed should be replaced or diluted whenever possible rather than relying on binders alone as the sole line of defense.

The Gap Between Lab Tests and Live Animals

A persistent problem in the mycotoxin binder field is that in vitro results often overestimate what happens in a living animal. Lab tests typically incubate a binder with a toxin in a buffer solution at a fixed pH, measure how much toxin disappears from solution, and call that the binding rate. The gut is far more complicated: pH shifts from acidic in the stomach to near-neutral or slightly alkaline in the intestine, bile salts compete for binding sites, the material is moving constantly, and other feed components are present.

Stability testing illustrates this gap. When researchers simulated both acidic stomach conditions and alkaline intestinal conditions and tracked whether toxins stayed bound over time, aflatoxin B1 complexes were generally stable with average adsorption rates near 97% in acid and 96% in alkaline conditions. But zearalenone-binder complexes were notably less stable under alkaline conditions, with some products releasing a substantial fraction of previously bound toxin as the pH shifted.²⁷ A binder that grabs a toxin in the stomach but releases it in the intestine, where absorption actually occurs, is not doing the animal any good. Dynamic gastrointestinal models, like the TIM system that simulates the pig digestive tract, have been used to get closer to real-world conditions when evaluating products like activated carbon against DON.²⁸

Regulation and What “Mycotoxin Binder” Actually Means Legally

In the European Union, mycotoxin binders fall under the feed additive regulation framework (EC No 1831/2003), specifically within the functional group of “substances for reduction of the contamination of feed by mycotoxins.” Applicants must demonstrate efficacy according to guidance from the European Food Safety Authority.²⁹ The EU is one of the more stringent regulatory environments; products need to show that they actually reduce toxin bioavailability in the target animal species, not just in a test tube.

In other regions, the regulatory picture is murkier. In the United States, some clay products are marketed under Generally Recognized As Safe (GRAS) status as anti-caking agents rather than specifically as mycotoxin binders, which allows them to enter the market without the same level of efficacy data. In many developing countries, where mycotoxin contamination is more severe and regulatory infrastructure is thinner, products of widely varying quality circulate with claims that may not be backed by rigorous testing. This is worth keeping in mind when evaluating commercial products: a binder authorized in the EU under a specific mycotoxin-reduction claim has cleared a higher evidence bar than one marketed informally as a “toxin binder” in a less regulated market.

Mycotoxins That Escape Into the Environment

One question that rarely gets attention in discussions of binders is what happens after the toxin-binder complex leaves the animal. When a clay-bound mycotoxin passes through the gut and ends up in manure, it enters the environment. Research on mycotoxins in soil has found that their retention is controlled largely by soil texture: clays in the soil naturally adsorb mycotoxins, while sandy soils allow them to leach toward groundwater. Whether the mycotoxins excreted in bound form remain bound once the manure is spread on fields, or whether environmental weathering releases them, is an area that has received far less study than the in-animal side of the equation. The widespread use of clay binders in intensive livestock operations means substantial quantities of mineral-bound mycotoxin residues are entering agricultural soils, and the long-term implications of that are not fully understood.